United Therapeutics Corp.
(NASDAQ : UTHR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
11.77%24.021.7%$252.26m
VRXValeant Pharmaceuticals International, Inc.
2.63%28.4814.1%$167.58m
BHCBausch Health Cos., Inc.
2.63%28.480.0%$119.07m
GWPHGW Pharmaceuticals Plc
2.26%108.416.2%$82.69m
MDCOThe Medicines Co.
2.14%51.9820.2%$80.72m
JAZZJazz Pharmaceuticals Plc
3.60%138.642.3%$64.51m
SAGESAGE Therapeutics, Inc.
3.93%146.328.6%$52.92m
PRGOPerrigo Co. Plc
2.83%49.406.8%$50.04m
ENDPEndo International Plc
8.89%4.538.8%$45.54m
UTHRUnited Therapeutics Corp.
1.01%90.4314.3%$39.52m
HZNPHorizon Therapeutics Plc
1.51%30.266.6%$38.93m
ICPTIntercept Pharmaceuticals, Inc.
-0.96%82.2516.9%$38.81m
ICLRICON plc
1.42%154.594.2%$37.69m
CTLTCatalent, Inc.
2.65%50.412.4%$31.87m
ARGXargenx SE
1.45%139.370.0%$26.47m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.